Headlines of narcolepsy related news

Wednesday, August 21, 2019 – PWN4PWN announces their attending at WUN Education Day on 21st of September in Vancouver, Canada.

Wednesday, August 14, 2019 – FDA Approves Pitolisant for Narcolepsy.

Thursday, March 21, 2019 – Solriamfetol/Sunosi is FDA approved.

Tuesday, March 12, 2019 – Inaugural World Narcolepsy Day to Take Place on Sept. 22, 2019. Read more about this article here.

Friday, December 21, 2018 – Jazz Pharma gets new PDUFA date for drug for excessive sleepiness solriamfetol/JZP-110. Read more about this article here.

Thursay, November 29, 2018 – Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating JZP-258 for the Treatment of Idiopathic Hypersomnia. Read more about this article here.

Friday, November 9, 2018 – Jazz Pharmaceuticals has filed a marketing application in Europe seeking approval for solriamfetol/JZP-110, a selective dopamine and norepinephrine reuptake inhibitor, to improve wakefulness and reduce excessive daytime sleepiness in adult patients with narcolepsy (with or without cataplexy) or obstructive sleep apnea.. Read more about this article here.